Metsera

Metsera ROA

Delisted

The Return on Assets (ROA) of Metsera (MTSR) as of Nov 3, 2026 is -46.37 %. In the previous year, Return on Assets (ROA) was -27.96 % — a change of 65.85% (lower).

ROA

-46.37 %

YoY

65.85%

Last updated:

In 2024, Metsera's return on assets (ROA) was -46.37 %, a 65.85% increase from the -27.96 % ROA in the previous year.

The Metsera ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2022
-5.43 USD
Jan 1, 2023
-27.96 USD
Jan 1, 2024
-46.37 USD
The Metsera ROA history
YEARROAYoY
-46.37 %+65.85%
-27.96 %+415.16%
-5.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

ROA Details

Understanding Metsera's Return on Assets (ROA)

Metsera's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Metsera's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Metsera's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Metsera’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Metsera stock

Return on Assets (ROA) of Metsera is -46.37 % in 2024.

Return on Assets (ROA) of Metsera changed from -27.96 % to -46.37 %, representing a 65.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Metsera since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Metsera with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Metsera

All Key Metrics — Metsera